An Open Label, Observational, Prospective Registry of Participants With Sickle Cell Disease (SCD) Treated With Oxbryta® (Voxelotor)® (Voxelotor)

30/09/2024
07/04/2025
EU PAS number:
EUPAS1000000170
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

GBT440-4R2 (C5341019) Registry Protocol (Prospective) GBT template 3 February 2021_FINAL.pdf

English (770.73 KB - PDF) View document
Updated protocol

No Pedigree GBT440-4R2 (C5341019)_Non-Interventional Study Protocol _Final_v1.0_10Oct2023.pdf

First published: 29/07/2024
English (1.6 MB - PDF) View document
Study results
Study report
Study report

C5341019 PROSPECT GBT440-4R2 Final NI Clinical Study Report_Redacted.pdf

English (10.16 MB - PDF) View document
Other information